Skip to content

We're in Beta! Found a bug? Let us know using the feedback button at the bottom right.

FolioFact
FolioFact
Q3 2026 56/68 funds filed
Latest observation
Sign in Sign up

Some record dates are in the future and are excluded from the latest observation date.

Stock overview

Crinetics Pharmaceuticals Inc.

Explore the company, reported ownership, price history, and available source evidence.

Historical Crinetics Pharmaceuticals common stock, traded as CRNX. Vertex acquired the company for $85.00 cash per share before trading opened on September 1, 2026. Nasdaq identifies August 31 as the last trading date.

Last close
$84.95
· CRNX
Tracked holders
0 funds
Latest available 13F per fund
Latest 13F filed
Date unavailable
Review reported holdings

CRNX · USD

Price

$84.95 +$61.38 (+260.42%) over selected range

Close · Aug 31, 2026

Market closed 1249 stored daily closes
$84.95 Aug 31, 2026
CRNX 5Y closing price chart 1249 stored daily closes from Aug 31, 2021–Aug 31, 2026. Low $15.31; high $84.95.
Aug 31, 2021Mar 1, 2024Aug 31, 2026
Range low
$15.31
Range high
$84.95
Observations
1249
Session date
Aug 31, 2026

Aug 31, 2021–Aug 31, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.

Investor Popularity

Latest reported institutional positions from SEC 13F filings.

0 holders

No tracked fund's latest available 13F reports CRNX.

This state describes the stored filings; it does not imply a current position.

SEC Forms 4/5

Insiders

Reported trades

Financials

Official-source analysis

AI Earnings Report

View all AI Earnings Reports

No published AI Earnings Report yet

We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.

Options market

Options

IV30 · daily

Send feedback

Optional — tap one if it fits

We'll only use this to respond to your feedback.